Cancer Clinical Trials

Clinical trials are an important part of the Johns Hopkins Kimmel Cancer Center's treatment options. Every treatment available today started as  a clinical trial.

Clinical trials, also known as studies, offer new treatment options for cancer patients. There are many different kinds of clinical trials. Your oncologist can describe the studies that may be a fit for you.

Don't be afraid to ask questions! Our doctors and nurses understand that there is a lot to consider when making decisions about treatment including participating in a clinical trial. Our videos help explain clinical trials so you and your healthcare team can make the choice that's right for you.

At the Kimmel Cancer Center, our experts recognize that cancer is a complex disease, and each patient is unique. To ensure that every patient receives treatment recommendations that are tailored precisely to their cancer, we request that those who are interested in one of our clinical trials, and who are not already a patient at the Kimmel Cancer Center, schedule a new patient consultation. To do this, please call 410-955-8964, and select option 2.

Search Cancer Clinical Trials

Find information about studies offered at the Johns Hokins Kimmel Cancer Center by using the ClinicalTrials.gov search below.

Power In Choices 

Clinical Trials: Hope and Anticipation

Learn more about the hope clinical trials can bring to cancer patients present and in the future at the Johns Hopkins Kimmel Cancer Center.

Clinical Trials: Expectations, Realities & Challenges

Meet a group of cancer patients who have taken part in clinical trials at the Johns Hopkins Kimmel Cancer Center. Learn about their expectations, realities and challenges they faced in joining a clinical trial.

Clinical Trials: Words & Phrases

Learn more and lessen fear about clinical trials at the Johns Hopkins Kimmel Cancer Center, by understanding the vocabulary and purpose of cancer clinical trials...

PRISMM

Patient Response to Immunotherapy using Spliceosome Mutational Markers or PRISMM is a Johns Hopkins trial for patients with advanced breast cancer whose tumors have been sequenced and have a spliceosome mutation (SF3B1)

 
Kimmel in the Community issue cover

Kimmel in the Community

A publication by the Johns Hopkins Kimmel Cancer Center.

Read the Latest Issue